President and CEO Travis McCready of the Massachusetts Life Sciences Center and Barry Greene, president and COO of Alnylam Pharmaceuticals, join necn to discuss the state of the industry, and the recent groundbreaking in Norton, MA.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
